XPD Asp312Asn polymorphism is a risk factor for prostate cancer
Journal of Cancer Research & Clinical Oncology,

Liao SG et al. – The results of this meta–analysis indicate that the Xeroderma pigmentosum Group D (XPD) Asp312Asn polymorphism is a risk factor for prostate cancer development.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore